Headline
The latest stories from AHA Today.
A Teachable Moment – a feature-length documentary that shares stories from four stroke survivors, as well as insights from experts that outline tangible measures to reduce risk factors for the neurological disorder – premiered last night.
U.S. births declined for the third year in a row in 2017 to 3.85 million, the fewest in 30 years, according to a new report by the Centers for Disease Control and Prevention.
The House Energy and Commerce Committee today approved more than 20 bills to address the opioid crisis.
The House of Representatives last night voted 347-70 to approve bipartisan legislation to streamline and consolidate the Department of Veterans Affairs’ community care programs into a permanent Veterans Community Care Program.
The Senate Appropriations Subcommittee on Financial Services and General Government today held a hearing on the Federal Communications Commission’s and Federal Trade Commission’s budget request for fiscal year 2019.
The Physician-Focused Payment Model Technical Advisory Committee recently submitted four recommendations to the Department of Health and Human Services, including a recommendation that the agency test the AHA-supported Advanced Care Model to support people with advanced illness. The Coalition…
The Food and Drug Administration today announced new efforts to spotlight situations where drugmakers may be pursuing “gaming tactics” to delay generic competition.
The AHA and seven other national hospital organizations yesterday voiced strong support for legislation that would allow states to receive federal matching funds for services provided to a Medicaid beneficiary with a substance use disorder in an Institution for Mental Disease.
Sens. Mike Lee (R-UT), Orrin Hatch (R-UT), Thom Tillis (R-NC) and Charles Grassley (R-IA) yesterday introduced the Standard Merger and Acquisition Reviews Through Equal Rules Act (S. 2847), AHA-supported legislation that would standardize the merger review process for the two federal antitrust…
The Food and Drug Administration today issued a final order exempting manufacturers from FDA premarket notification requirements for certain N95 respirators, disposable devices used to protect patients and health care providers from infection.